Sundaram Preethi 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Sundaram Preethi
Chief Strategy Officer
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-06-10$26.41/sh−2,324$61,377→ 42,681 total - Sale
Common Stock, par value $0.001 per share
2025-06-11$26.42/sh−1,600$42,272→ 41,081 total
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.